Javed Anees: Treatable Mitochondrial Disorders We Must Not Miss
Javed Anees, Medical Consultant at Government of Kerala, shared a post on LinkedIn:
“Mitochondria series: 6
Treatable Mitochondrial Disorders: Diagnoses We Must Not Miss
Many disorders presenting with mitochondrial dysfunction are no longer synonymous with untreatable progressive disease.
Advances in metabolic medicine and genomic diagnostics have identified several conditions in which timely recognition and disease-specific therapy can significantly alter outcomes.
I recently prepared this infographic to provide a practical, genetics-first approach to recognizing treatable mitochondrial and mitochondrial-related metabolic disorders, including:
- Biotinidase deficiency
- Holocarboxylase synthetase deficiency
- Primary Coenzyme Q10 deficiency
- Riboflavin transporter deficiency
- Multiple acyl-CoA dehydrogenase deficiency (MADD)
- Pyruvate dehydrogenase complex deficiency
- Primary carnitine deficiency
- Lipid storage myopathies
The poster highlights key clinical red flags, diagnostic pathways, metabolic investigations, disease-specific therapies, and common diagnostic pitfalls, with the aim of supporting clinicians in everyday practice.
The most important message is simple: recognize early, investigate systematically, and initiate appropriate therapy promptly when indicated. For several of these disorders, early intervention may prevent irreversible neurological and systemic complications.
I hope this resource is useful for neurologists, internists, pediatricians, neuromuscular specialists, and trainees involved in the care of patients with suspected mitochondrial disease.
I welcome your comments, suggestions, and discussion.”

Stay updated with Hemostasis Today.
-
Jul 29, 2026, 17:41Seema Dawood: Difference Between CBC Smear Staining and Cell Counts Staining
-
Jul 29, 2026, 16:30Mostafa Faisal: Impact of DNMT3A and TET2 Mutations on Clotting and Bleeding in PV and ET
-
Jul 29, 2026, 16:01Gerardo Moscatelli: The Spike Protein Cascade – From Endothelial Binding to Vascular Collapse
-
Jul 29, 2026, 15:42Julie Cardoso: FDA Clears the First AI-Guided Ultrasound Software for Suspected DVT
-
Jul 29, 2026, 15:26Ahmad Alkhammash: Completing an Advanced Fellowship in Adult Thrombosis Medicine
-
Jul 29, 2026, 15:13Yara Mahmoud: The Molecular Basis in Hematology
-
Jul 29, 2026, 15:11Louisa Jorm: A New Era of Dynamic Cardiovascular Risk Assessment
-
Jul 29, 2026, 15:04Filippo Consonni: Treatment Strategies for Hematologic Immune Dysregulation in Inborn Errors of Immunity
-
Jul 29, 2026, 14:53Samer Alsaid: Warfarin Outcomes Reassessed Through COMBINE AF